212 related articles for article (PubMed ID: 33160435)
1. Kojic Acid for Melasma: Popular Ingredient in Skincare Products.
Zachary CM; Wang JV; Saedi N
Skinmed; 2020; 18(5):271-273. PubMed ID: 33160435
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
3. Natural ingredients for darker skin types: growing options for hyperpigmentation.
Alexis AF; Blackcloud P
J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
[TBL] [Abstract][Full Text] [Related]
4. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid.
Lim JT
Dermatol Surg; 1999 Apr; 25(4):282-4. PubMed ID: 10417583
[TBL] [Abstract][Full Text] [Related]
5. Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen.
Thornfeldt C; Rizer RL; Trookman NS
J Drugs Dermatol; 2013 Dec; 12(12):1449-54. PubMed ID: 24301247
[TBL] [Abstract][Full Text] [Related]
6. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
Grimes PE
Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
[TBL] [Abstract][Full Text] [Related]
7. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions.
Garcia A; Fulton JE
Dermatol Surg; 1996 May; 22(5):443-7. PubMed ID: 8634807
[TBL] [Abstract][Full Text] [Related]
8. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
9. Topical treatments for melasma and postinflammatory hyperpigmentation.
Lynde CB; Kraft JN; Lynde CW
Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
[TBL] [Abstract][Full Text] [Related]
10. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
11. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
[TBL] [Abstract][Full Text] [Related]
13. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
Rendon MI; Barkovic S
J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.
Lyons A; Stoll J; Moy R
J Drugs Dermatol; 2018 Sep; 17(9):970-973. PubMed ID: 30235384
[TBL] [Abstract][Full Text] [Related]
15. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial.
Griffiths CE; Finkel LJ; Ditre CM; Hamilton TA; Ellis CN; Voorhees JJ
Br J Dermatol; 1993 Oct; 129(4):415-21. PubMed ID: 8217756
[TBL] [Abstract][Full Text] [Related]
16. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Use of Antioxidants for Melasma.
Babbush KM; Babbush RA; Khachemoune A
J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation.
Goberdhan L; Schneider K; Makino ET; Bautista A; Mehta RC
J Cosmet Dermatol; 2024 May; 23(5):1726-1733. PubMed ID: 38288515
[TBL] [Abstract][Full Text] [Related]
19. The top 10 cosmeceuticals for facial hyperpigmentation.
Searle T; Al-Niaimi F; Ali FR
Dermatol Ther; 2020 Nov; 33(6):e14095. PubMed ID: 32720446
[TBL] [Abstract][Full Text] [Related]
20. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
